Table 1.

The general demographics of the participants.

Variable	Response	Frequency	Percentage (%)
Sex	Male	525	51.2
	Female	501	48.8
Hypertension	No	412	40.0
	Yes	617	60.0
Diabetes Mellitus	No	588	57.1
	Yes	442	42.9
Hyperlipidemia	No	731	71.0
	Yes	299	29.0
Heart Failure	No	889	87.0
	Yes	133	13.0
Chronic Kidney Disease	No	466	48.4
	Yes	49	5.1
Atrial Fibrillation	No	982	95.3
	Yes	48	4.7
Other Arrhythmias	No	506	70.6
	Yes	211	29.4
MACE	No	787	76.4
	Yes	243	23.6
Medications	Metformin	157	15.3
	Angiotensin Converting Enzyme Inhibitor	147	14.3
	Angiotensin Receptor Blocker	200	19.4
	Diuretics	143	13.9
	Insulin	245	23.8
	Beta Blockers	241	23.4
	Anti-platelet	131	12.6
	Anti-coagulants	157	15.2
	Calcium Channel Blockers	116	11.3
	Alpha Blockers	22	2.1
Type of Positional OSA	NPOSA	599	57.8
	POSA	431	41.6
Type of REM OSA	REM-OSA	211	26.1
	NREM-OSA	596	73.9

Variable	Mean	SD	Range
Age (years)	59.78	14.01	18–101
Creatinine (mg/dl)	1.43	0.72	0.34–5.21
Hb1AC	6.64	1.56	0.86–13.00
Systolic Blood Pressure	141.83	13.84	60–211
Diastolic Blood Pressure	83.24	8.46	30–140
High Density Lipoprotein	45.33	20.9	3–449
Low Density Lipoprotein	113.44	39.4	9–258
Triglyceride	165.48	89.25	31–738
Urea	122.75	437.60	2.23–616.52
Brain Natriuretic Peptide	53.67	246.85	0–3449.25
Left Atrial Pressure	4.48	0.86	2.6–9.0
Left Ventricular End Diastolic Diameter (millimeters)	29.63	30.23	4.00–503.00
Ejection Fraction	53.43	8.27	16–89
Pulmonary Artery Pressure	47.89	14.06	19–90